Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title [RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience]
Creator Trouche-Sabatier et al.
Author S. G. Trouche-Sabatier
Author X. Rebillard
Author F. Iborra
Author D. Azria
Author J.-P. Daures
Author G. Poinas
Author N. Abdo
Author O. Delbos
Author A. Gevorgyan
Author S. Marchal
Author R. Guillon
Author I. Millet
Author P.-J. Lamy
Author O. Lauche
Author R. Reis-Borges
Author I. Serre
Author D. Topart
Abstract PURPOSE: In 2016, the Herault tumor registry collected 1961cancers in urology (21.4 % from all Herault cancers this year). RHESOU was created to complete RTH' data with specific parameters in onco-urology. The aim of this study is to describe RHESOU and to give some examples with our first results. MATERIAL AND METHODS: In November 2018, RHESOU (Registry HErault Specialised in Onco-Urology) was founded with the same registry recommendations. It collects specific oncologic parameters and also complete RTH's data. For each urological cancer, a specific survey with different choices was performed to collect a maximum of data which could be present in patients' file. These surveys were used for urological cancers cases that live in Herault in 2017. RESULTS: In 2017, we collected 970 prostate cancers, 581 bladder cancers, 212 kidney cancers, 51 upper excretory tract cancers, 28 testicle cancers and 9 penil cancers. Our urological data collection gives many possibilities to create many requests for detailed analysis in urological cancers. In this article, we reported data from kidney, bladder and prostate cancers. CONCLUSIONS: RHESOU is a new tool opened to the different urologic corporations (urologists, pathologists, oncologists, radiotherapists, radiologists) that permits an overview in urological cancers in Herault. Finally, one important aim is that this tool will be adapted when new treatments or new important parameters appear in the years ahead. LEVEL OF EVIDENCE: 3.
Publication Progres En Urologie: Journal De l'Association Francaise D'urologie Et De La Societe Francaise D'urologie
Volume 30
Issue 16
Pages 1038-1044
Date 2020-12
Journal Abbr Prog Urol
Language fre
DOI 10.1016/j.purol.2020.09.015
ISSN 1166-7087
Short Title [RHESOU (Registry in HErault Specialized in Onco-Urology)
Library Catalog PubMed
Extra Number: 16 PMID: 33012630
Tags Base de données, Cancers génitaux masculins, Cancers urologiques, Cancers urologiques féminins, clinic, Épidémiologie, Epidemiology, Female, France, Humans, Kidney Neoplasms, Male, Male and female urological cancers, Male genital cancers, Medical Oncology, Prostatic Neoplasms, Registre, Registries, Urinary Bladder Neoplasms, Urologic Neoplasms
Date Added 2023/11/23 - 12:48:38
Date Modified 2024/12/15 - 11:29:30
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés